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1003 Historical perspectives of The American Association for Thoracic Surgery:
Robert Edward Gross (1905–1988)(continued on page 12A
The Journal of Thoracic and Cardiovascular Surgery c Volume 143, Number 5 11AJoseph W. Turek, MD, PhD, and J. William Gaynor, MD, Iowa City, Iowa, and Philadelphia, PaAcquired Cardiovascular
Disease (ACD)
1S007 Less invasive surgical treatment for aortic arch aneurysms in high-risk
patients: A comparative study of hybrid thoracic endovascular aortic repair
and conventional total arch replacementG
TTakashi Murashita, MD, Hitoshi Matsuda, MD, Keitaro Domae, MD, Yutaka Iba, MD,
Hiroshi Tanaka, MD, Hiroaki Sasaki, MD, and Hitoshi Ogino, MD, Osaka, JapanA less invasive hybrid procedure involving supra-aortic bypass and endovascular stent-graft
placement for aortic arch aneurysms was indicated in high-risk patients. The impact of this
procedure was assessed by evaluating the early and midterm outcomes compared with those of
conventional total arch replacement.1S014 Simplified perfusion strategy for removing retroperitoneal tumors with
extensive cavoatrial involvement/B
ETJose L. Navia, MD, Nicolas A. Brozzi, MD, Edward R. Nowicki, MD, MS,
Eugene H. Blackstone, MD, Venkatesh Krishnamurthi, MD, Martin G. Sinkewich, CCP,
Jeevanantham Rajeswaran, MSc, Gregory Pattakos, MD, MS, and Bruce W. Lytle, MD,
Cleveland, OhioRadical nephrectomy and removal of retroperitoneal tumor–thrombus with extensive cavoatrial
involvement can be performed simply, effectively, and safely with beating-heart cardiopulmonary
bypass, avoiding the deleterious effects of hypothermic circulatory arrest and providing clinical
benefit without increasing morbidity or mortality.1T022 A phase 2 prospective, randomized, double-blind trial comparing the effects of
tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery
with cardiopulmonary bypass (CONSERV-2 Trial)X
Paula M. Bokesch, MD, Gabor Szabo, MD, Ryszard Wojdyga, MD, Hilary P. Grocott, MD, FRCPC,
Peter K. Smith, MD, C. David Mazer, MD, FRCPC, Santosh Vetticaden, MD, PhD,
Alistair Wheeler, MD, and Jerrold H. Levy, MD, FAHA, Lexington and Boston, Mass;
Heidelberg, Germany; Warsaw, Poland; Winnipeg, Manitoba, and Toronto, Ontario, Canada;
Durham, NC; and Atlanta, GaPMThis prospective multinational, randomized, double-blind trial compared the efficacy of ecallantide
with tranexamic acid to decrease blood transfusion in patients undergoing cardiac surgery by using
cardiopulmonary bypass for procedures associated with a high risk of bleeding. Ecallantide was
less effective at reducing perioperative blood loss than tranexamic acid. High-dose tranexamic acid
was more effective than the low dose in reducing blood loss.)
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PM112A The Journal of Thoracic an030 Coronary perfusion: Impact of flow dynamics and geometric design of 2
different aortic prostheses of similar size(continued on page 14A
d Cardiovascular Surgery c May 2012Vito Mannacio, MD, Luigi Di Tommaso, MD, Vincenzo De Amicis, MD, Paolo Stassano, MD, and
Carlo Vosa, MD, Naples, ItalyThis study compared 2 similarly sized aortic prostheses (mechanical and porcine) regarding
coronary flow and hemodynamic performance after surgery for pure aortic stenosis. Conclusions
were that bioprostheses showed more evident improvement of coronary flow and superior
hemodynamics during exercise.1036 Beneficial effects of the CorCap cardiac support device: Five-year results from
the Acorn Trial
Douglas L. Mann, MD, Spencer H. Kubo, MD, Hani N. Sabbah, PhD, Randall C. Starling, MD,
Mariell Jessup, MD, Jae K. Oh, MD, and Michael A. Acker, MD, St Paul and Rochester, Minn;
Detroit, Mich; Cleveland, Ohio; Philadelphia, Pa; and St Louis, MoThis report of 5-year follow-up of the non–mitral valve repair stratum of the Acorn Trial shows that
treatment with a cardiac support device was safe in long-term follow-up and that there were
continued significant reductions in LV end-diastolic volume and structure and an improvement in
NYHA class.1043 Tricuspid valve surgery: The past 10 years from the Nationwide Inpatient
Sample (NIS) database
Christina M. Vassileva, MD, John Shabosky, BA, Theresa Boley, MSN, Stephen Markwell, MA, and
Stephen Hazelrigg, MD, Springfield, IllThere has been a dramatic increase in tricuspid interventions over time, with associated increase in
tricuspid repair rates and use of bioprostheses for tricuspid replacement. Mortality for tricuspid
valve surgery decreased over time. Nevertheless, mortality remains considerable (10.6% overall)
and significantly higher for replacement than for repair.1050 Increased risk of dehiscence after tricuspid valve repair with rigid
annuloplasty rings
Bettina Pfannm€uller, MD, Torsten Doenst, MD, PHD, Katja Eberhardt, BS, J€org Seeburger, MD,
Michael A. Borger, MD, PhD, and Friedrich W. Mohr, MD, PhD, Leipzig, GermanySurgical correction of tricuspid regurgitation mainly consists of tricuspid valve annuloplasty,
performed with either a rigid ring or a flexible band. Our analysis revealed that although acceptable
results can be achieved with either annuloplasty device, implantation of a rigid ring increases the
risk of postoperative ring dehiscence.1056 Multivessel beating heart robotic myocardial revascularization increases
morbidity and mortality
Richa Dhawan, MD, Joseph Devin Roberts, MD, Kristen Wroblewski, MS, Jeffrey A. Katz, MD,
Jai Raman, MD, PhD, and Mark A. Chaney, MD, Chicago, IllThe present retrospective review of 106 patients undergoing total endoscopic coronary artery
bypass (72% multivessel) indicates that addressing multivessel coronary artery disease using this
technology might increase the morbidity and mortality.)
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PM114A The Journal of Thoracic an062 Fifteen-year experience with minimally invasive approach for reoperations
involving the mitral valve(continued on page 15A
d Cardiovascular Surgery c May 2012Joseph M. Arcidi, Jr, MD, Evelio Rodriguez, MD, Joseph R. Elbeery, MD, L. Wiley Nifong, MD,
Jimmy T. Efird, PhD, and W. Randolph Chitwood, Jr, MD, Greenville, NCIn 15 years, we performed minimally invasive right thoracotomy for 167 reoperations involving the
mitral valve to avoid reoperative sternotomy risk. Mitral repair rate and procedure complexity
increased with experience. Mortality and stroke rate were 3.0% and 2.4%, respectively; there was
no statistical relationship with fibrillatory arrest, used in 77%.Congenital Heart
Disease (CHD)
1069 Differential effects of aprotinin and tranexamic acid on outcomes and cytokine
profiles in neonates undergoing cardiac surgery
Eric M. Graham, MD, Andrew M. Atz, MD, Jenna Gillis, MS, Stacia M. DeSantis, PhD,
A. Lauren Haney, PharmD, Rachael L. Deardorff, MS, Walter E. Uber, PharmD,
Scott T. Reeves, MD, Francis X. McGowan, Jr, MD, Scott M. Bradley, MD, and
Francis G. Spinale, MD, PhD, Charleston, SCAprotinin, compared with tranexamic acid, was associated with reduced perioperative blood
product use, improved early indices of postoperative recovery, and attenuated proinflammatory
cytokine production, without apparent early adverse effects in neonates undergoing cardiac
operations.1077 The improvement of hypoxia correlates with neuroanatomic and
developmental outcomes: Comparison of midterm outcomes in infants with
transposition of the great arteries or single-ventricle physiology
Keijiro Ibuki, MD, Kazuhiro Watanabe, MD, Naoki Yoshimura, MD, Tachiyo Kakimoto, MA,
Mie Matsui, MD, Taketoshi Yoshida, MD, Hideki Origasa, PhD, and Fukiko Ichida, MD,
Toyama, JapanNeuroanatomic and developmental outcomes improve progressively in infants with TGA, unlike
those with SV physiology. Neurodevelopmental assessment scores are positively associated with
regional brain volume, and functional oxygen saturation is associated with whole and frontal brain
volumes. Impaired cerebral circulation and hypoxia may have significant effects on brain growth
and development in infants with congenital heart disease.1086 Hepatic blood flow distribution and performance in conventional and novel
Y-graft Fontan geometries: A case series computational fluid dynamics
study
Weiguang Yang, MS, Irene E. Vignon-Clementel, PhD, Guillaume Troianowski, MS,
V. Mohan Reddy, MD, Jeffrey A. Feinstein, MD, MPH, and Alison L. Marsden, PhD, La Jolla and
Stanford, Calif; and Le Chesnay Cedex, FranceThe Y-graft Fontan design achieves overall superior hemodynamic performance compared with
traditional designs. However, the results emphasize that no one-size-fits-all solution is available
that will universally benefit all patients and that designs should be customized for individual
patients before clinical application.)
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CD1098 Coarctectomy combined with an interdigitating arch reconstruction results in
a lower incidence of recurrent arch obstruction after the Norwood procedure
than coarctectomy alone(continued on page 16A
The Journal of Thoracic and Cardiovascular Surgery c Volume 143, Number 5 15ALuke J. Lamers, MD, Peter C. Frommelt, MD, Kathleen A. Mussatto, RN, PhD,
Robert D. B. Jaquiss, MD, Michael E. Mitchell, MD, and James S. Tweddell, MD, Milwaukee, WisCH
DIn this retrospective study of 142 Norwood procedures, 2 techniques of arch reconstruction were
compared: coarctectomy alone (n 5 79) versus coarctectomy plus an interdigitating arch
anastomosis (n 5 63). Coarctectomy plus an interdigitating arch anastomosis resulted in
a decreased incidence of intervention for recurrent arch obstruction (P 5 .001).1103 Long-term importance of right ventricular outflow tract patch function in
patients with pulmonary regurgitation
Rajesh Puranik, MD, Victor Tsang, MD, Philip Lurz, MD, Vivek Muthurangu, MD,
Sophie Offen, MBBS, Alessandra Frigiola, MD, Wendy Norman, DCR, Fiona Walker, MD,
Philip Bonhoeffer, MD, and Andrew M. Taylor, MD, London, United KingdomS
G
TRVOT patch dysfunction is an important determinant of long-term outcomes in ToF. Patients with
a similar degree of pulmonary regurgitation secondary to pulmonary stenosis treated with
valvotomy have more favorable ventricular volumes and contractile function. These observations
highlight the importance of the initial repair surgery in ToF for late outcomes.1108 Visualization of flow structures in Fontan patients using 3-dimensional phase
contrast magnetic resonance imagingSKartik S. Sundareswaran, PhD, Christopher M. Haggerty, BS, Diane de Zelicourt, PhD,
Lakshmi P. Dasi, PhD, Kerem Pekkan, PhD, David H. Frakes, PhD, Andrew J. Powell, MD,
Kirk R. Kanter, MD, Mark A. Fogel, MD, and Ajit P. Yoganathan, PhD, Atlanta, Ga; Fort Collins,
Colo; Pittsburgh and Philadelphia, Pa; Tempe, Ariz; and Boston, MassET
/BComparisons of in vivo 3D hemodynamics were made between lateral tunnel and extracardiac
Fontan connections using magnetic resonance imaging. Results demonstrated distinctive
differences in the qualitative flow features: lateral tunnels generally exhibiting large recirculation
regions, whereas extracardiacs had a more streamlined profile.1117 Changes in left atrioventricular valve geometry after surgical repair of
complete atrioventricular canal
Elisabeth Kaza, MD, Gerald R. Marx, MD, Aditya K. Kaza, MD, Steven D. Colan, MD,
Hugo Loyola, MS, Douglas P. Perrin, PhD, and Pedro J. del Nido, MD, Boston, MassTXThis study sought to determine the changes in left atrioventricular valve geometry that affect leaflet
coaptation after surgical repair using 2-dimensional echocardiographic imaging and quantification.General Thoracic
Surgery (GTS)
1125 The use of a tailored surgical technique for minimally invasive esophagectomy
Jeffrey Javidfar, MD, Matthew Bacchetta, MD, Jonathan A. Yang, MD, MPH, Joanna Miller, BS,
Frank D’Ovidio, MD, PhD, Mark E. Ginsburg, MD, Lyall A. Gorenstein, MD, Marc Bessler, MD,
and Joshua R. Sonett, MD, New York, NYPMWhen the surgical technique (transhiatal, transthoracic, or 3-hole) for minimally invasive
esophagectomy is tailored to the anatomy and oncologic needs of each patient, it can be performed
safely while maintaining oncologic equivalence and providing comparable lymph node dissection.)
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PM116A The Journal of Thoracic an130 Evolving progress in oncologic and operative outcomes for esophageal and
junctional cancer: Lessons from the experience of a high-volume center(continued on page 18A
d Cardiovascular Surgery c May 2012John V. Reynolds, MD, Claire L. Donohoe, MB, Erin McGillycuddy, MSc, Naraymasamy Ravi, MD,
Dermot O’Toole, MD, Ken O’Byrne, MD, and Donal Hollywood, MD, Dublin, IrelandModern benchmarks in esophageal cancer management include (1) a cure rate of approximately
40% in patients treated with curative intent and (2) low postoperative mortality rates. This study of
1067 patients highlights evolving trends, including changes in patterns of care, an increase in early
diagnoses, higher nodal yields, and an increased use of nonoperative approaches.1138 Operative techniques in robotic thoracic surgery for inferior or posterior
mediastinal pathology
Robert James Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD, and
Douglas J. Minnich, MD, FACS, Birmingham, AlaRobotic surgery is safe and effective for pathology in the inferior or posterior mediastinum and for
anterior mediastinal tumors. Our experience in 75 such patients is reviewed. The different technical
maneuvers, such as alterations in patient positioning and robotic orientation that optimize the
operation, are related.1144 Thoracic empyema in patients with liver cirrhosis: Clinical characteristics and
outcome analysis of thoracoscopic management
Ke-Cheng Chen, MD, Jou-Wei Lin, MD, MPH, PhD, Yu-Ting Tseng, MD, Shuenn-Wen Kuo, MD,
Pei-Ming Huang, MD, Hsao-Hsun Hsu, MD, PhD, Jang-Ming Lee, MD, PhD, and
Jin-Shing Chen, MD, PhD, Yun-Lin County, Hsin-Chu County, and Taipei, TaiwanManagement of thoracic empyema in cirrhotic patients is a clinical challenge and associated with
a high mortality. Our study showed that, with proper patient selection, thoracoscopic management
is feasible and may provide a better chance of survival than nonthoracoscopic management.Evolving Technology/
Basic Science (ET/BS)
1152 Nanocoating with titanium reduces iC3b- and granulocyte-activating immune
response against glutaraldehyde-fixed bovine pericardium: A new technique to
improve biologic heart valve prosthesis durability?
Norbert W. Guldner, MD, Fabienne Bastian, MD, G€unther Weigel, MD,
Hanng€org Zimmermann, MS, Markus Maleika, MS, Michael Scharfschwerdt, MS,
Daniel Rohde, MS, and Hans-Hinrich Sievers, MD, L€ubeck and N€urnberg, Germany; and Vienna,
AustriaNanocoating with titanium significantly reduces the iC3b to 38% 6 21% and the granulocyte-
activating immune response of GA-fixed pericardium to 6.3%. Therefore, it might prevent relevant
immune rejections and might increase the durability of GA-fixed bio-prosthetic heart valves and
enable the use of GA-fixed valves even in young patients.1160 Clinical implications and molecular mechanisms of immunoparalysis after
cardiopulmonary bypass
Timothy T. Cornell, MD, Lei Sun, PhD, Mark W. Hall, MD, James G. Gurney, PhD,
Matthew J. Ashbrook, BS, Richard G. Ohye, MD, and Thomas P. Shanley, MD,
Ann Arbor, Mich, and Columbus, OhioWe used an ex vivo whole blood stimulation assay to immunophenotype pediatric patients after
cardiopulmonary bypass. This assay allowed us to identify a cohort of patients at low risk for
developing postoperative infections.)
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PM118A The Journal of Thoracic an167 The nondepolarizing, normokalemic cardioplegia formulation
adenosine-lidocaine (adenocaine) exerts anti-neutrophil effects by synergistic
actions of its components(continued on page 20A
d Cardiovascular Surgery c May 2012Weiwei Shi, MD, PhD, Rong Jiang, MD, PhD, Geoffrey P. Dobson, PhD, Asger Granfeldt, MD, and
Jakob Vinten-Johansen, PhD, Atlanta, Ga, Townsville, Australia, and Aarhus, DenmarkThe combination of adenosine and lidocaine (adenocaine; Hibernation Therapeutics Global Ltd,
Kilquade, Ireland) is used in cardioplegia to arrest the heart in a polarized state or at lower
concentrations to reduce potassium required to achieve arrest. This study shows that adenocaine
also exerts anti-inflammatory effects directly on neutrophils by suppressing superoxide anion
generation and adhesionmolecule expression in isolated porcine neutrophils to a greater extent than
either drug alone.1176 Creating an ideal ‘‘off-test mode’’ for rotary left ventricular assist devices:
Establishing a safe and appropriate weaning protocol after myocardial
recovery
Masahiko Ando, MD, PhD, Takashi Nishimura, MD, PhD, Yoshiaki Takewa, MD, PhD,
Shunei Kyo, MD, PhD, Minoru Ono, MD, PhD, Yoshiyuki Taenaka, MD, PhD, and
Eisuke Tatsumi, MD, PhD, Tokyo, JapanFor successful device LVAD removal, appropriate patient selection and precise evaluation of
cardiac function are essential. We developed a novel ‘‘off-test mode’’ for rotary LVAD weaning,
which increases revolutions per minute just in diastole. The EVAHEART device was installed in 8
goats, and we evaluated LV workload and retrograde pump flow under 3 conditions: circuit clamp,
continuous mode, and off-test mode. Off-test mode decreased retrograde pump flow during
weaning while keeping LV workload similar to circuit clamp. This mode is potentially valuable for
establishing a safe and appropriate pump weaning protocol after myocardial recovery.Cardiothoracic
Transplantation (TX)
1183 Outcomes after transplantation for ‘‘failed’’ Fontan: A single-institution
experience
Ryan R. Davies, MD, Robert A. Sorabella, MD, Jonathan Yang, MD, Ralph S. Mosca, MD,
Jonathan M. Chen, MD, and Jan M. Quaegebeur, MD, PhD, Wilmington, Del, and New York, NYAn analysis of 43 patients undergoing transplantation for ‘‘failed’’ Fontan from a single institution
was undertaken to assess the pretransplantation predictors of post-transplant survival. Early
mortality was greater among Fontan patients than patients with other congenital heart disease, and
renal failure was the strongest predictor of early mortality.1193 Benefits of ambulatory axillary intra-aortic balloon pump for circulatory
support as bridge to heart transplant
Ramanan Umakanthan, MD, Steven J. Hoff, MD, Natalia Solenkova, MD, Mark A. Wigger, MD,
Mary E. Keebler, MD, Andrew Lenneman, MD, Marzia Leacche, MD, Thomas G. DiSalvo, MD,
Henry Ooi, MD, Allen J. Naftilan, MD, John G. Byrne, MD, and Rashid M. Ahmad, MD,
Nashville, TennAxillary intra-aortic balloon pump therapy has been described as a bridge to transplant. Advantages
over femoral intra-aortic balloon pump therapy include enhancedmobility.We conducted a study to
evaluate outcomes in selected patients and observed marked improvement in ambulatory potential
and hemodynamic parameters. The majority of patients were successfully bridged to
transplantation.)
Table of Contents (continued)A
CD
CH
D
G
TS
ET/B
S
TX
PMPerioperative
Management (PM)
120A The Journal of Thoracic an198 Intraoperative use of recombinant activated factor VII during complex aortic
surgery(continued on page 22A
d Cardiovascular Surgery c May 2012Deniz Goksedef, MD, Georgia Panagopoulos, PhD, Naiem Nassiri, MD, Randy L. Levine, MD,
Panagiotis G. Hountis, MD, and Konstadinos A. Plestis, MD, New York, NYRecombinant activated factor VII is increasingly used for the postoperative management of
bleeding in cardiac surgery. We report our experience with the intraoperative use of this agent after
aortic surgery.1205 Selective cerebral perfusion for thoracic aortic surgery: Association with
neurocognitive outcome
Suzan Uysal, PhD, Hung-Mo Lin, PhD, Gregory W. Fischer, MD, Gabriele Di Luozzo, MD, and
David L. Reich, MD, New York, NYNeurocognitive outcomes were studied in 57 adult patients undergoing cardiac or other thoracic
aortic surgery with different methods of neuroprotection. Duration of antegrade selective cerebral
perfusion was a significant predictor of decline in memory and language test scores.1213 Recognition of heparin-induced thrombocytopenia and initiation of
argatroban therapy after cardiothoracic surgery in the intensive care unit
Linda J. Demma, MD, PhD, Christopher A. Paciullo, PharmD, BCPS, and
Jerrold H. Levy, MD, FAHA, Atlanta, GaCurrent data regarding the safety of argatroban in the postoperative cardiothoracic surgical patient
in the intensive care setting are limited. The results from this study demonstrate that argatroban can
be considered without increased risk for adverse events in the cardiothoracic intensive care unit
after surgery on clinical suspicion of heparin-induced thrombocytopenia.Cardiothoracic
Imaging
1219 Titanium plates for primary closure of complete sternal cleft in an adult:
Five-year follow-up
Khaled E. Al-Ebrahim, FRCSC, and Husain H. Jabbad, FRCSC, Jeddah, Saudi ArabiaSurgical Techniques 1221 Adult extracorporeal membrane oxygenation and gastrointestinal bleeding
from small bowel arteriovenous malformations: A novel treatment using spiral
enteroscopy
Konrad Sarosiek, MD, Hitoshi Hirose, MD, Harrison T. Pitcher, MD, and
Nicholas C. Cavarocchi, MD, Philadelphia, Pa1223 Middle and posterior cardiac veins: An underused option for ventricular
pacing
Henry M. Spotnitz, MD, and Daniel Y. Wang, MD, New York, NY1225 Early experience with the transaortic approach for transcatheter aortic valve
implantation
Gopal Soppa, MRCS, PhD, David Roy, MD, Stephen Brecker, FRCP, and
Marjan Jahangiri, FRCS (CTh), London, United Kingdom)
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PM122A The Journal of Thoracic an227 Carotid artery and jugular vein cannulation in aortic redo surgery
Paul P. Urbanski, MD, PhD, Bad Neustadt, Germany(continued on page 25A
d Cardiovascular Surgery c May 2012Online Only:
Case Reports
e41 Quantitative assessment of right ventricular function in pectus
excavatum
Rajeev L. Narayan, MD, Prashant Vaishnava, MD, Jose M. Castellano, MD, PhD, and
Valentin Fuster, MD, PhD, New York, NY, and Madrid, Spaine42 A new echocardiographic window to visualize the mitral valve complex during
mitral valve repair for functional mitral regurgitation
Kikuko Obase, MD, PhD, Masashi Komeda, MD, PhD, Hiroyuki Okura, MD, PhD, and
Kiyoshi Yoshida, MD, PhD, Kurashiki and Nagoya, JapanLetters to the Editor 1230 Open versus endovascular repair for acute traumatic thoracic aortic rupture
Alain Verdant, MD, Montreal, Quebec, Canada1230 Reply to the Editor
Ludovic Canaud, MD, and Pierre Alric, MD, PhD, Montpellier, France1231 Does anastomosis device or epiaortic ultrasonography reduce the risk of
postoperative stroke after coronary artery bypass grafting?
Fausto Biancari, MD, PhD, Oulu, Finland1232 Reply to the Editor
Maximilian Y. Emmert, MD, Sacha P. Salzberg, MD, and Volkmar Falk, MD,
Zurich, Switzerland1232 Simulation of thoracoscopic surgery using 3-dimensional tailor-made virtual
lung
Tadashi Akiba, MD, Toshiaki Morikawa, MD, and Takao Ohki, MD, Kashiwa, Chiba, and
Minatoku, Tokyo, Japan1234 Guiding the molecular diagnosis of hypertrophic cardiomyopathy
Christian Geier, MD, Eric Schulze-Bahr, MD, and Gisele Bonne, PhD, Berlin and M€unster,
Germany; and Paris, France1234 Re: Simplified perfusion strategy for removing retroperitoneal tumors with
extensive cavoatrial involvement
Javier Gonzalez, MD, Thomas Salerno, MD, and Gaetano Ciancio, MD, Madrid, Spain, and
Miami, Fla)
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Surgery recertification (2012;143:521-2).The Journal of Thoracic and Cardiovascular Surgery c Volume 143, Number 5 25A1CH
D235 Correction of article by Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges
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2011 ACCF/AHA guideline for coronary artery bypass graft surgery:
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